Results

Total Results: 1,702 records

Showing results for "cancer".
Users also searched for: colon cancer screening

  1. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-update_research-protocol.pdf
    April 01, 2013 - tumors are considered potentially indolent.13 Although the primary measure of tumor aggressiveness … EMBASE (EMTREE) Neoplasms/ Prostate/ Prostatic Neoplasms/ Cancer* Carcinoma* Neoplasm* Prostat … Prostatic Neoplasms/ 2 Prostate cancer (prostat$.ti,ab. or Prostate/) AND (cancer.ti,ab. or Neoplasms … /radiotherapy”[mesh] 2 Prostate cancer “prostatic neoplasms”[mesh] OR (prostat*[tiab] AND (neoplasm* … “prostate cancer” OR (prostat* AND (neoplasm* OR cancer* OR carcinoma*)) 2 Treatment options “watchful
  2. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_surveillance.pdf
    August 01, 2012 - [mh] OR neoplas* OR malignan* OR cancer OR cancers OR cancerous OR tumor OR tumors OR tumour OR tumours … [mh] OR neoplas* OR malignan* OR cancer OR cancers OR cancerous OR tumor OR tumors OR tumour OR tumours … [mh] OR neoplas* OR malignan* OR cancer OR cancers OR cancerous OR tumor OR tumors OR tumour OR tumours … visit, date of report of cancer, or death Development of a neoplasm as evidenced in medical records … Recurrence of pituitary or CNS tumors was reported in 6 (1.4%) patients; recurrence of other neoplasias
  3. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_surveillance.pdf
    July 01, 2012 - 21 23 4 and 22 24 19 or 23 25 (chemoprevent$ adj3 (breast$ adj2 (neoplas$ or tumor$ or cancer$ … / or (breast$ adj2 (neoplas$ or tumor$ or cancer$ or malignan$)).mp.- 9-limit 8 to (english language … / or (breast$ adj2 (neoplas$ or tumor$ or cancer$ or malignan$)).mp. 2-tibolone.mp. 3-exp breast/ … / or (breast$ adj2 (neoplas$ or tumor$ or cancer$ or malignan$)).mp. 2-exp risk assessment/ or risk … / or (breast adj2 (cancer$ or tumor$ or malignan$ or carcino$ or neoplas$)).mp. 4-limit 3 to (english
  4. effectivehealthcare-admin.ahrq.gov/products/prostate-cancer-therapies-update/research-protocol
    December 01, 2019 - tumor grade in terms of the Gleason score, which ranges from 2 to 10. 4 Gleason 8–10 tumors are considered … tumors are considered potentially indolent. 13 Although the primary measure of tumor aggressiveness … EMBASE (EMTREE) Neoplasms/ Prostate/ Prostatic Neoplasms/ Cancer* Carcinoma* … or Neoplasms/ or neoplasm$ or carcinoma$) 3 Combine sets S1 OR S2 4 Treatment options … “prostate cancer” OR (prostat* AND (neoplasm* OR cancer* OR carcinoma*)) 2 Treatment options
  5. effectivehealthcare-admin.ahrq.gov/health-topics/cancer?page=1
    January 19, 2010 - These extra cells can form a mass called a tumor. Tumors can be benign or malignant. … Benign tumors aren't cancer while malignant ones are. … Cells from malignant tumors can invade nearby tissues. … There are more than 100 different types of cancer. Most cancers are named for where they start. … For example, lung cancer starts in the lung, and breast cancer starts in the breast.
  6. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_research-protocol.pdf
    March 13, 2012 - Background Stage II Colon Cancer Colon cancer is a common malignancy affecting both women and … Stage II colon cancer is characterized by full-thickness tumor invasion of the bowel wall and the absence … tumors that directly penetrate to the surface of the visceral peritoneum), and IIC (T4b tumors where … Draft Search Strategy for Ovid MEDLINE 1. exp Colorectal Neoplasms/ 2. … ((colorectal or colon$ or rectal or Sigmoid) adj3 (neoplasm$ or cancer$ or carcino$ or tumo?
  7. effectivehealthcare-admin.ahrq.gov/health-topics/lung-cancer
    December 11, 2018 - Description Lung cancer is one of the most common cancers in the world. … It is a leading cause of cancer death in men and women in the United States. … Cigarette smoking causes most lung cancers. … Targeted therapy uses substances that attack cancer cells without harming normal cells. … and Endobronchial Obstruction Due to Advanced Lung Tumors Research Report December 20, 2011
  8. effectivehealthcare-admin.ahrq.gov/products/skin-lesions-evaluation/research-protocol
    December 01, 2019 - malignancies. … examine how these emerging non-invasive imaging modalities could be used to help diagnose cancerous tumors … whether or not patients have a history of other malignancies. … The rationale for this is the growing recognition of skin cancer as a leading form of second malignancy … Association of nonmelanoma skin cancer with second malignancy.
  9. effectivehealthcare-admin.ahrq.gov/products/liver-cancer/research
    December 01, 2019 - Structured Abstract Objectives Hepatocellular carcinoma (HCC) is the most common primary malignantneoplasm of the liver, and accurate diagnosis and staging of HCC are important for guiding treatment … analyses were conducted to evaluate the effects of the reference standard used and study, patient, tumor … Protocol Dec 20, 2024 Primary Hypofractionated Radiation Therapy for Localized Prostate Cancer … https://effectivehealthcare.ahrq.gov/products/liver-cancer/research  
  10. effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/diagnosis-and-treatment-of-non-muscle-invasive-bladder-cancer
    November 01, 2020 - , cystoscopy, urine cytology, urine-based biomarkers, transurethral resection of bladder tumor (TURBT … How do tumor characteristics (stage, grade, multiplicity, size, molecular and genetic alterations) predict … perhaps replace cytology and cystoscopy in the diagnosis and surveillance of patients with urothelial cancers … Genetic and epidemiological evidence indicates that African Americans may have a more aggressive form of malignancy … for 90% of all malignant tumors.
  11. effectivehealthcare-admin.ahrq.gov/products/bladder-cancer-non-muscle-invasive/research-protocol
    December 01, 2020 - Stage 2 cancers are muscle-invasive, and higher stage cancers invade beyond the muscle layer into surrounding … . 7 As many as 70 percent of Non-MIBC tumors will recur after initial treatment, with a 10-20 percent … These include the stage of the cancer, tumor grade, whether the tumor is an initial tumor or a recurrence … and Treatment of Non-metastatic Muscle-invasive Bladder Cance r exp Urinary Bladder Neoplasms/ … or 28 (215263) 7 and 29 (231) 9 or 11 or 20 or 22 or 24 or 26 or 30 (2005) exp Urinary Bladder Neoplasms
  12. effectivehealthcare-admin.ahrq.gov/products/bladder-cancer-muscle-invasive/research-protocol
    December 01, 2020 - Stage 2 cancers are muscle-invasive, and higher stage cancers invade beyond the muscle layer into surrounding … Stage T4b cancer, in which the tumor has spread to the pelvis or abdominal wall, bladder cancer involving … Approximately 25 percent of newly diagnosed bladder cancers present as stage 2 or higher tumors. 6 Once … These include the stage of the cancer, tumor grade, whether the tumor is an initial tumor or a recurrence … and Treatment of Non-metastatic Muscle-invasive Bladder Cancer exp Urinary Bladder Neoplasms/ (42649
  13. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/liver-cancer_executive.pdf
    October 01, 2014 - Executive Summary Background and Objectives Hepatocellular carcinoma (HCC) is the most common primary malignantneoplasm of the liver, usually developing in individuals with chronic liver disease or cirrhosis. … Worldwide, it is the fifth most common cancer and the third most common cause of cancer death.1 There … National Cancer Institute. Liver Cancer. www.cancer.gov/ cancertopics/types/liver. … SEER Cancer Statistics Review, 1975-2010.
  14. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/liver-cancer-therapy_research-protocol.pdf
    November 28, 2012 - Unlike most solid tumors, the future incidence of and mortality rate due to HCC are projected to increase … using the following string of search terms: "Carcinoma, Hepatocellular"[Mesh] OR (hepatocellular AND (neoplasm … * OR cancer OR cancers OR carcinoma)) AND Unresectable OR nonresectable OR inoperable OR irresectable … comparative studies, and case series by using the following string of search terms: hepatocellular AND (neoplasm … * OR cancer OR cancers OR carcinoma) AND (unresectable OR nonresectable OR inoperable OR irresectable
  15. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/liver-cancer-therapy_executive.pdf
    May 01, 2013 - One study reported cancer-free survival (from time of study treatment to local tumor progression), extrahepatic … Authors varied in how these tumor characteristics were described: mean number and size of tumors, median … number and size of tumors, range of number and size of tumors, percent solitary and nonsolitary tumors … Hepatobiliary Cancers. Version 2. 2010. … Treatment of large and/ or multiple hepatic malignancies: open surgical approaches of radiofrequency
  16. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/bladder-cancer-muscle-invasive_research-protocol.pdf
    July 21, 2014 - Stage 2 cancers are muscle-invasive, and higher stage cancers invade beyond the muscle layer into surrounding … Stage T4b cancer, in which the tumor has spread to the pelvis or abdominal wall, bladder cancer involving … Approximately 25 percent of newly diagnosed bladder cancers present as stage 2 or higher tumors.6 Once … These include the stage of the cancer, tumor grade, whether the tumor is an initial tumor or a recurrence … and Treatment of Non- metastatic Muscle-invasive Bladder Cancer 1. exp Urinary Bladder Neoplasms/
  17. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/rapid-response-chemotherapy-dental.pdf
    July 01, 2023 - The cancer conditions included acute leukemias, clinically advanced multiple myeloma, solid tumors with … Management of the neck in early oral cancers: Is the verdict out? … potential dental focal infection before the first cycle of chemotherapy in patients with hematologic malignancy … searched: December 16, 2022 1 Bone Marrow Transplantation/ or exp Immunosuppression Therapy/ or exp Neoplasms … leukemia* or lymphom* or malig* or neoplas* or onco* or radiat* or radiotherap* or "radio-therap*" or tumor
  18. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-protocol_amended110619.pdf
    November 02, 2019 - non-dermatologic malignancy (174,650 new cases) and the second leading cause of cancer death (31,620 … With AS, tumors are not immediately removed, irradiated, or ablated.3, 4 Instead, tumors are monitored … Stage 1 T2= tumor Stage 2 T3= tumor Stage 3 T4= tumor Stage 4 WMD= weighted mean differences WW … / (121506) 2 (prostat* and (neoplasm* or cancer* or carcinoma*)).ti,ab. (142514) 3 watchful … / (9241) 2 (prostat$.ti,ab. or Prostate/) and (cancer.ti,ab. or Neoplasms/ or neoplasm$.mp. or
  19. effectivehealthcare-admin.ahrq.gov/products/prostate-cancer-radiation/research
    December 01, 2019 - outcomes, especially in higher risk tumors, although evidence is lacking. … Prior examinations of the same database have shown tumor characteristics such as size or stage to be … Higher doses of CRT are associated with lower tumor recurrence rates. … If CRT becomes less accessible, we may expect IMRT use to increase in other tumors, perhaps even in tumors … Monitoring IMRT use should be a priority for these other cancers as well as for groups of prostate cancer
  20. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/skin-lesions-evaluation_research-protocol.pdf
    August 23, 2010 - cancer in men and women, accounting for nearly half of all malignancies. … examine how these emerging non-invasive imaging modalities could be used to help diagnose cancerous tumors … whether or not patients have a history of other malignancies. … The rationale for this is the growing recognition of skin cancer as a leading form of second malignancy … Association of nonmelanoma skin cancer with second malignancy. Cancer 2004 January 1;100(1):130-8.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: